Trial Profile
A randomised phase II two-arm clinical trial of cisplatin and radiation plus or minus CUDC-101 in patients with head and neck cancer.
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 17 Aug 2011
Price :
$35
*
At a glance
- Drugs Cisplatin (Primary) ; CUDC 101 (Primary)
- Indications Head and neck cancer
- Focus Therapeutic Use
- 17 Aug 2011 New trial record